New England Journal of Medicine, volume 377, issue 14, pages 1357-1367

Challenges in the Design and Interpretation of Noninferiority Trials

Laura Mauri

Ralph B. D'Agostino

Show full list: 2 authors

Publication type: Journal Article

Publication date: 2017-10-04

Massachusetts Medical Society

Journal: New England Journal of Medicine

scimago Q1

SJR: 20.544

CiteScore: 145.4

Impact factor: 96.2

ISSN: 00284793, 15334406

DOI: 10.1056/NEJMra1510063

Copy DOI

PubMed ID: 28976859

General Medicine

Abstract

In this review, the authors consider the characteristics and challenges of noninferiority trial designs, including seven essential features of noninferiority trials.

Found 0

Clear filter

By date By citations

Found 0

Clear filter

By date By citations

Top-30

Journals

	2 4 6 8 10 12
New England Journal of Medicine	New England Journal of Medicine, 11, 4.2% New England Journal of Medicine 11 publications, 4.2%
Trials	Trials, 9, 3.44% Trials 9 publications, 3.44%
BMJ Open	BMJ Open, 8, 3.05% BMJ Open 8 publications, 3.05%
The Lancet	The Lancet, 5, 1.91% The Lancet 5 publications, 1.91%
The Lancet Oncology	The Lancet Oncology, 5, 1.91% The Lancet Oncology 5 publications, 1.91%
JAMA - Journal of the American Medical Association	JAMA - Journal of the American Medical Association, 5, 1.91% JAMA - Journal of the American Medical Association 5 publications, 1.91%
JAMA network open	JAMA network open, 5, 1.91% JAMA network open 5 publications, 1.91%
Journal of Clinical Epidemiology	Journal of Clinical Epidemiology, 4, 1.53% Journal of Clinical Epidemiology 4 publications, 1.53%
Clinical Trials	Clinical Trials, 3, 1.15% Clinical Trials 3 publications, 1.15%
The Lancet Infectious Diseases	The Lancet Infectious Diseases, 3, 1.15% The Lancet Infectious Diseases 3 publications, 1.15%
PLoS Medicine	PLoS Medicine, 3, 1.15% PLoS Medicine 3 publications, 1.15%
Journal of Thoracic and Cardiovascular Surgery	Journal of Thoracic and Cardiovascular Surgery, 3, 1.15% Journal of Thoracic and Cardiovascular Surgery 3 publications, 1.15%
Statistics in Medicine	Statistics in Medicine, 3, 1.15% Statistics in Medicine 3 publications, 1.15%
BMJ	BMJ, 3, 1.15% BMJ 3 publications, 1.15%
Clinical Infectious Diseases	Clinical Infectious Diseases, 3, 1.15% Clinical Infectious Diseases 3 publications, 1.15%
Regional Anesthesia and Pain Medicine	Regional Anesthesia and Pain Medicine, 3, 1.15% Regional Anesthesia and Pain Medicine 3 publications, 1.15%
JAMA Internal Medicine	JAMA Internal Medicine, 3, 1.15% JAMA Internal Medicine 3 publications, 1.15%
Stroke	Stroke, 3, 1.15% Stroke 3 publications, 1.15%
JACC Advances	JACC Advances, 3, 1.15% JACC Advances 3 publications, 1.15%
American Journal of Respiratory and Critical Care Medicine	American Journal of Respiratory and Critical Care Medicine, 2, 0.76% American Journal of Respiratory and Critical Care Medicine 2 publications, 0.76%
Obstetrics and Gynecology	Obstetrics and Gynecology, 2, 0.76% Obstetrics and Gynecology 2 publications, 0.76%
Journal of Clinical Medicine	Journal of Clinical Medicine, 2, 0.76% Journal of Clinical Medicine 2 publications, 0.76%
European Journal of Epidemiology	European Journal of Epidemiology, 2, 0.76% European Journal of Epidemiology 2 publications, 0.76%
American Journal of Obstetrics and Gynecology	American Journal of Obstetrics and Gynecology, 2, 0.76% American Journal of Obstetrics and Gynecology 2 publications, 0.76%
Vaccine	Vaccine, 2, 0.76% Vaccine 2 publications, 0.76%
Clinical Microbiology and Infection	Clinical Microbiology and Infection, 2, 0.76% Clinical Microbiology and Infection 2 publications, 0.76%
Contemporary Clinical Trials Communications	Contemporary Clinical Trials Communications, 2, 0.76% Contemporary Clinical Trials Communications 2 publications, 0.76%
JAMA Psychiatry	JAMA Psychiatry, 2, 0.76% JAMA Psychiatry 2 publications, 0.76%
European Journal of Cardio-thoracic Surgery	European Journal of Cardio-thoracic Surgery, 2, 0.76% European Journal of Cardio-thoracic Surgery 2 publications, 0.76%
	2 4 6 8 10 12

Publishers

	10 20 30 40 50 60 70 80
Elsevier	Elsevier, 73, 27.86% Elsevier 73 publications, 27.86%
Springer Nature	Springer Nature, 26, 9.92% Springer Nature 26 publications, 9.92%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 25, 9.54% Ovid Technologies (Wolters Kluwer Health) 25 publications, 9.54%
Wiley	Wiley, 23, 8.78% Wiley 23 publications, 8.78%
American Medical Association (AMA)	American Medical Association (AMA), 21, 8.02% American Medical Association (AMA) 21 publications, 8.02%
BMJ	BMJ, 16, 6.11% BMJ 16 publications, 6.11%
Massachusetts Medical Society	Massachusetts Medical Society, 12, 4.58% Massachusetts Medical Society 12 publications, 4.58%
Oxford University Press	Oxford University Press, 11, 4.2% Oxford University Press 11 publications, 4.2%
SAGE	SAGE, 8, 3.05% SAGE 8 publications, 3.05%
Taylor & Francis	Taylor & Francis, 5, 1.91% Taylor & Francis 5 publications, 1.91%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 4, 1.53% Public Library of Science (PLoS) 4 publications, 1.53%
MDPI	MDPI, 3, 1.15% MDPI 3 publications, 1.15%
American Thoracic Society	American Thoracic Society, 2, 0.76% American Thoracic Society 2 publications, 0.76%
Frontiers Media S.A.	Frontiers Media S.A., 2, 0.76% Frontiers Media S.A. 2 publications, 0.76%
Hindawi Limited	Hindawi Limited, 2, 0.76% Hindawi Limited 2 publications, 0.76%
AME Publishing Company	AME Publishing Company, 2, 0.76% AME Publishing Company 2 publications, 0.76%
Mary Ann Liebert	Mary Ann Liebert, 1, 0.38% Mary Ann Liebert 1 publication, 0.38%
Society of Nuclear Medicine	Society of Nuclear Medicine, 1, 0.38% Society of Nuclear Medicine 1 publication, 0.38%
Social Science Electronic Publishing	Social Science Electronic Publishing, 1, 0.38% Social Science Electronic Publishing 1 publication, 0.38%
Society for Translational Oncology	Society for Translational Oncology, 1, 0.38% Society for Translational Oncology 1 publication, 0.38%
American Society of Nephrology	American Society of Nephrology, 1, 0.38% American Society of Nephrology 1 publication, 0.38%
National Coordinating Centre for Health Technology Assessment	National Coordinating Centre for Health Technology Assessment, 1, 0.38% National Coordinating Centre for Health Technology Assessment 1 publication, 0.38%
American Veterinary Medical Association	American Veterinary Medical Association, 1, 0.38% American Veterinary Medical Association 1 publication, 0.38%
American Association for Cancer Research (AACR)	American Association for Cancer Research (AACR), 1, 0.38% American Association for Cancer Research (AACR) 1 publication, 0.38%
American Society of Hematology	American Society of Hematology, 1, 0.38% American Society of Hematology 1 publication, 0.38%
American Society of Clinical Oncology (ASCO)	American Society of Clinical Oncology (ASCO), 1, 0.38% American Society of Clinical Oncology (ASCO) 1 publication, 0.38%
Annual Reviews	Annual Reviews, 1, 0.38% Annual Reviews 1 publication, 0.38%
American Diabetes Association	American Diabetes Association, 1, 0.38% American Diabetes Association 1 publication, 0.38%
Europa Ed	Europa Ed, 1, 0.38% Europa Ed 1 publication, 0.38%
	10 20 30 40 50 60 70 80

We do not take into account publications without a DOI.
Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

n/a Field Citation Ratio

8.66 Relative Citation Ratio

Cite this

GOST |

Cite this

GOST Copy

Mauri L., D'Agostino R. B. Challenges in the Design and Interpretation of Noninferiority Trials // New England Journal of Medicine. 2017. Vol. 377. No. 14. pp. 1357-1367.

GOST all authors (up to 50) Copy

Mauri L., D'Agostino R. B. Challenges in the Design and Interpretation of Noninferiority Trials // New England Journal of Medicine. 2017. Vol. 377. No. 14. pp. 1357-1367.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1056/NEJMra1510063

UR - https://doi.org/10.1056/NEJMra1510063

TI - Challenges in the Design and Interpretation of Noninferiority Trials

T2 - New England Journal of Medicine

AU - Mauri, Laura

AU - D'Agostino, Ralph B.

PY - 2017

DA - 2017/10/04

PB - Massachusetts Medical Society

SP - 1357-1367

IS - 14

VL - 377

PMID - 28976859

SN - 0028-4793

SN - 1533-4406

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2017_Mauri,

author = {Laura Mauri and Ralph B. D'Agostino},

title = {Challenges in the Design and Interpretation of Noninferiority Trials},

journal = {New England Journal of Medicine},

year = {2017},

volume = {377},

publisher = {Massachusetts Medical Society},

month = {oct},

url = {https://doi.org/10.1056/NEJMra1510063},

number = {14},

pages = {1357--1367},

doi = {10.1056/NEJMra1510063}

}

MLA

Cite this

MLA Copy

Mauri, Laura, and Ralph B. D'Agostino. “Challenges in the Design and Interpretation of Noninferiority Trials.” New England Journal of Medicine, vol. 377, no. 14, Oct. 2017, pp. 1357-1367. https://doi.org/10.1056/NEJMra1510063.

Found error?

Message

Support chat

Publisher

Massachusetts Medical Society

Journal

New England Journal of Medicine

scimago Q1

SJR

20.544

CiteScore

145.4

Impact factor

96.2

ISSN

00284793

15334406

Profiles

Cabitta, Livia